Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Altundag

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2021
Association between HER2 status in residual disease and sensitivity to trastuzumab emtansineK Altundag
British Dental Journal|February 24, 2018
No studiesK Altundag
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 11, 2017
Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancerK Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2008
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?H Harputluoglu, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 19, 2011
Clinical and pathological characteristics of occult breast cancer and review of the literatureE Altan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 29, 2012
A case of familial nasopharyngeal carcinoma: is screening necessary for siblings?U Sahin, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancerB Isik, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 15, 2012
Synchronous presentation of breast cancer and hepatocellular carcinoma in a postmenopausal woman: dual action of aromatase inhibitor on breast and hepatic cancer cells?D S Dede, K Altundag
British Journal of Cancer|January 13, 2006
Human papilloma virus and breast cancerK Altundag, M Z Baptista
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 19, 2011
Percentage of family history of cancer in patients with breast cancer: Is it changing with ethnicity?O Dizdar, C Arslan, K Altundag
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2021
Association between HER2 status in residual disease and sensitivity to trastuzumab emtansineK Altundag
British Dental Journal|February 24, 2018
No studiesK Altundag
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 11, 2017
Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancerK Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2008
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?H Harputluoglu, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 19, 2011
Clinical and pathological characteristics of occult breast cancer and review of the literatureE Altan, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 29, 2012
A case of familial nasopharyngeal carcinoma: is screening necessary for siblings?U Sahin, K Altundag
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancerB Isik, K Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 15, 2012
Synchronous presentation of breast cancer and hepatocellular carcinoma in a postmenopausal woman: dual action of aromatase inhibitor on breast and hepatic cancer cells?D S Dede, K Altundag
British Journal of Cancer|January 13, 2006
Human papilloma virus and breast cancerK Altundag, M Z Baptista
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 19, 2011
Percentage of family history of cancer in patients with breast cancer: Is it changing with ethnicity?O Dizdar, C Arslan, K Altundag
Pageof 9